Key Events This Week
21 Sep: Sharp open interest surge amid mixed market signals
23 Sep: Stock rallies to ₹9,060.25, near 52-week high
24 Sep: Upgraded to Strong Buy on robust fundamentals and technicals
25 Sep: Significant open interest surge amid mixed price action
Monday, 21 September: Open Interest Surges Amid Mixed Signals
Apollo Hospitals began the week with a strong 1.94% gain to close at Rs.8,940.00, outperforming the Sensex’s 0.46% rise. This price action coincided with a notable 14.17% increase in open interest in the derivatives segment, rising from 38,060 to 43,454 contracts. Futures volume was robust at 35,878 contracts, with combined futures and options value exceeding ₹50,000 crores, signalling heightened market activity.
Despite this surge, the stock underperformed its hospital sector peers by 1.66% on the day, reflecting a cautious stance among traders. The stock traded near its 52-week high of Rs.9,050, supported by strong technicals including trading above all key moving averages. Delivery volumes rose sharply, indicating increased investor participation and conviction.
Wednesday, 23 September: Rally Near 52-Week Highs
On 23 September, Apollo Hospitals surged 1.94% to close at Rs.9,060.25, marking the week’s highest closing price and approaching its 52-week high of Rs.9,326.80. This rally was accompanied by a significant increase in trading volume, with 20,595 shares changing hands, reflecting renewed buying interest.
The stock’s strong performance contrasted with the Sensex’s modest 0.56% gain, underscoring Apollo’s relative strength. This price move was supported by bullish technical indicators, including daily moving averages and Bollinger Bands, which suggested expanding upward momentum. The stock’s resilience amid mixed market conditions highlighted its defensive qualities within the healthcare sector.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Thursday, 24 September: Upgrade to Strong Buy on Fundamentals and Technicals
MarketsMOJO upgraded Apollo Hospitals from a 'Buy' to a 'Strong Buy' rating on 23 September, reflecting improvements in quality, valuation, financial trends, and technical indicators. The company’s Return on Capital Employed (ROCE) stood at a robust 17.13%, with net sales reaching ₹7,043.50 crores in Q1 FY26-27 and net profit growth of 10.31% for the quarter.
This upgrade was supported by attractive valuation metrics, including an EV/CE ratio of 8.6 and a PEG ratio of 1.8, indicating that price appreciation is well supported by earnings growth. Apollo’s stock price had appreciated 17.92% over the past year, outperforming the Sensex significantly. Institutional investors hold a substantial 65.44% stake, underscoring confidence in the company’s prospects.
Technically, the stock exhibited bullish momentum with daily moving averages and Bollinger Bands signalling strength. Monthly MACD and KST indicators turned bullish, while weekly signals remained mildly bullish, suggesting a strengthening trend. The stock closed the day at Rs.8,900.00, down 1.77%, reflecting some profit-taking amid the upgrade announcement.
Thinking about Apollo Hospitals Enterprise Ltd.? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this large-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Friday, 25 September: Open Interest Surges Amid Mixed Price Action
The week closed with a slight decline of 0.11% to Rs.8,889.90, as Apollo Hospitals experienced a minor pullback following two consecutive down days. Despite this, open interest in derivatives surged 15.86% to 46,336 contracts, accompanied by strong volume of 41,584 contracts, indicating active repositioning by traders.
The stock traded within a narrow intraday range of Rs.1.5, reflecting consolidation near resistance levels. Technically, it remained above its 20-day, 100-day, and 200-day moving averages but below the 5-day and 50-day averages, signalling short-term resistance. Delivery volumes increased by 12.61%, suggesting sustained investor interest despite recent volatility.
This mixed price action alongside elevated derivatives activity suggests a complex market stance, with some participants hedging or positioning for a breakout. The stock outperformed its sector, which declined 1.62%, and the Sensex, which fell 0.11%, reinforcing its relative strength.
Weekly Price Performance: Apollo Hospitals vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.8,940.00 | +1.94% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.8,887.75 | -0.58% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.9,060.25 | +1.94% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.8,900.00 | -1.77% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.8,889.90 | -0.11% | 35,353.29 | +0.18% |
Key Takeaways
Positive Signals: Apollo Hospitals outperformed the Sensex by 2.12% over the week, closing near its 52-week highs. The upgrade to a Strong Buy rating reflects robust fundamentals, including strong ROCE, consistent net profit growth, and attractive valuation metrics. Technical indicators such as bullish daily moving averages and monthly MACD support sustained upward momentum. Elevated open interest and volume in derivatives highlight active market participation and potential for directional moves.
Cautionary Notes: The stock experienced short-term resistance, trading below its 5-day and 50-day moving averages late in the week, accompanied by minor price declines. Weekly MACD and KST indicators remain mildly bearish, suggesting possible consolidation or profit-taking. The mixed price action alongside surging open interest indicates a complex market stance, with traders hedging or awaiting fresh catalysts. Investors should monitor volume and open interest trends closely to assess the sustainability of the current momentum.
Conclusion
Apollo Hospitals Enterprise Ltd. demonstrated resilience and relative strength during a week marked by mixed market signals and active derivatives positioning. The stock’s 1.36% weekly gain against a declining Sensex underscores its defensive qualities and robust fundamentals. The recent upgrade to Strong Buy by MarketsMOJO, supported by improved financial metrics and bullish technical momentum, reinforces confidence in the company’s medium- to long-term prospects.
While short-term volatility and technical resistance warrant caution, the stock’s liquidity, institutional backing, and market leadership position it well for potential further gains. Investors and traders should maintain a balanced approach, closely tracking evolving price and volume dynamics to navigate the nuanced market environment surrounding Apollo Hospitals.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
